Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lymph Node Involvement by a Clear Cell Nodular Hidradenoma-Like Tumor of Uncertain Malignant Potential.

Autor: Au B; Department of Pathology, Lakeridge Health, Oshawa, Ontario, Canada., Sidiropoulos KG; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Ghazarian D; Department of Pathology, Lakeridge Health, Oshawa, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Department of Pathology, University Health Network, Toronto, Ontario, Canada., Sidiropoulos M; Department of Pathology, Lakeridge Health, Oshawa, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Department of Pathology, University Health Network, Toronto, Ontario, Canada.

Publikováno v: The American Journal of dermatopathology [Am J Dermatopathol] 2017 Dec; Vol. 39 (12), pp. 953-954.

MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.

Autor: Nofech-Mozes R; Department of Laboratory Medicine and the Keenan Research Centre for Biomedical Science at the Li KaShing Knowledge Institute, St. Michael's Hospital, Toronto, M5B 1W8, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Khella HW; Department of Laboratory Medicine and the Keenan Research Centre for Biomedical Science at the Li KaShing Knowledge Institute, St. Michael's Hospital, Toronto, M5B 1W8, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Scorilas A; Departments of Biochemistry and Molecular Biology, University of Athens, 15701, Athens, Greece., Youssef L; Department of Laboratory Medicine and the Keenan Research Centre for Biomedical Science at the Li KaShing Knowledge Institute, St. Michael's Hospital, Toronto, M5B 1W8, Canada., Krylov SN; Departments of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, M3J 1P3, Canada., Lianidou E; Department of Chemistry, University of Athens, 15771, Athens, Greece., Sidiropoulos KG; Department of Laboratory Medicine and the Keenan Research Centre for Biomedical Science at the Li KaShing Knowledge Institute, St. Michael's Hospital, Toronto, M5B 1W8, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Gabril M; Department of Pathology, London Health Sciences Center and Western University, London, N6A 5W9, Canada., Evans A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Yousef GM; Department of Laboratory Medicine and the Keenan Research Centre for Biomedical Science at the Li KaShing Knowledge Institute, St. Michael's Hospital, Toronto, M5B 1W8, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, Canada.

Publikováno v: Cancer medicine [Cancer Med] 2016 Apr; Vol. 5 (4), pp. 656-64. Date of Electronic Publication: 2016 Feb 10.

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.

Autor: Sidiropoulos KG; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., White NM; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Bui A; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada., Ding Q; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada., Boulos P; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada., Pampalakis G; Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece., Khella H; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada., Samuel JN; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada., Sotiropoulou G; Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece., Yousef GM; The Keenan Research Center for Biomedical Sciences at the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Canada ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Publikováno v: Oncoscience [Oncoscience] 2014 Oct 24; Vol. 1 (11), pp. 709-24. Date of Electronic Publication: 2014 Oct 24 (Print Publication: 2014).